These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8242591)

  • 1. Cell lineage involvement in four patients with myelodysplastic syndrome and t(1;7) or trisomy 8 studied by simultaneous immunophenotyping and fluorescence in situ hybridization.
    Nylund SJ; Verbeek W; Larramendy ML; Ruutu T; Heinonen K; Hallman H; Knuutila S
    Cancer Genet Cytogenet; 1993 Oct; 70(2):120-4. PubMed ID: 8242591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined immunophenotyping and DNA in situ hybridization to study lineage involvement in patients with myelodysplastic syndromes.
    Kibbelaar RE; van Kamp H; Dreef EJ; de Groot-Swings G; Kluin-Nelemans JC; Beverstock GC; Fibbe WE; Kluin PM
    Blood; 1992 Apr; 79(7):1823-8. PubMed ID: 1558974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal cell lineage involvement in myelodysplastic syndromes studied by fluorescence in situ hybridization and morphology.
    Bernell P; Jacobsson B; Nordgren A; Hast R
    Leukemia; 1996 Apr; 10(4):662-8. PubMed ID: 8618444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescence in situ hybridization of progenitor cells obtained by fluorescence-activated cell sorting for the detection of cells affected by chromosome abnormality trisomy 8 in patients with myelodysplastic syndromes.
    Saitoh K; Miura I; Takahashi N; Miura AB
    Blood; 1998 Oct; 92(8):2886-92. PubMed ID: 9763574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantifying chromosome changes and lineage involvement in myelodysplastic syndrome (MDS) using fluorescent in situ hybridization (FISH).
    Han K; Lee W; Harris CP; Kim W; Shim S; Meisner LF
    Leukemia; 1994 Jan; 8(1):81-6. PubMed ID: 8289503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of lineage involvement by trisomy 8 in myelodysplastic syndrome. A multiparameter analysis combining conventional cytogenetics, DNA in situ hybridization, and bone marrow culture studies.
    Fagioli F; Cuneo A; Bardi A; Carli MG; Bigoni R; Balsamo R; Previati R; Pazzi I; Roberti G; Rigolin GM
    Cancer Genet Cytogenet; 1995 Jul; 82(2):116-22. PubMed ID: 7664240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined immunophenotyping and in situ hybridization (FICTION): a rapid method to study cell lineage involvement in myelodysplastic syndromes.
    Soenen V; Fenaux P; Flactif M; Lepelley P; Lai JL; Cosson A; Preudhomme C
    Br J Haematol; 1995 Jul; 90(3):701-6. PubMed ID: 7647013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal CD5-positive B lymphocytes in myelodysplastic syndrome with systemic vasculitis and trisomy 8.
    Billström R; Johansson B; Strömbeck B; el-Rifai W; Larramendy M; Olofsson T; Mitelman F; Knuutila S
    Ann Hematol; 1997 Jan; 74(1):37-40. PubMed ID: 9031614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytogenetic clonality analysis in myelodysplastic syndrome: monosomy 7 can be demonstrated in the myeloid and in the lymphoid lineage.
    van Lom K; Hagemeijer A; Smit E; Hählen K; Groeneveld K; Löwenberg B
    Leukemia; 1995 Nov; 9(11):1818-21. PubMed ID: 7475268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetic clonality in myelodysplastic syndromes studied with fluorescence in situ hybridization: lineage, response to growth factor therapy, and clone expansion.
    Anastasi J; Feng J; Le Beau MM; Larson RA; Rowley JD; Vardiman JW
    Blood; 1993 Mar; 81(6):1580-5. PubMed ID: 8453104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical and experimental study of 38 cases with trisomy 8].
    Xu WL; Jin J; Chen ZM; Lou JY; Yu YB
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Dec; 20(6):528-31. PubMed ID: 14669224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conventional and molecular cytogenetic features of myelodysplastic syndrome in China.
    Chen L; Li J; Zhu Y; Qiu H; Pan J; Wang R; Qian S; Xu W; Xue Y
    Exp Oncol; 2007 Dec; 29(4):299-303. PubMed ID: 18199987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of trisomy 8 with interphase fluorescence in situ hybridization in myelodysplastic syndromes].
    Li J; Pan J; Xue Y; Wu C; Xie X; Guo Y; Ruan C
    Zhonghua Xue Ye Xue Za Zhi; 2000 Apr; 21(4):179-81. PubMed ID: 11876976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interphase cytogenetic analysis of in vivo differentiation in the myelodysplasia of Down syndrome.
    Zipursky A; Wang H; Brown EJ; Squire J
    Blood; 1994 Oct; 84(7):2278-82. PubMed ID: 7919346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of clonality in myelodysplastic syndromes: detection of trisomy 8 in bone marrow cell smears by fluorescence in situ hybridization.
    Abruzzese E; Buss D; Rainer R; Rao PN; Pettenati MJ
    Leuk Res; 1996 Jul; 20(7):551-7. PubMed ID: 8795688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of trisomy 8 and monosomy 7 in chronic granulocytic leukemia and myelodysplastic syndrome by cytogenetic analysis and fluorescence in situ hybridization].
    Szabó Gabriella P; Balogh E; Jakab Z; Germán P; Bodnár F; Kiss A; Telek B; Oláh E
    Orv Hetil; 2002 Dec; 143(50):2775-9. PubMed ID: 12583317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of natural killer cells in patients with myelodysplastic syndrome carrying monosomy 7 revealed by the application of fluorescence in situ hybridization to cells collected by means of fluorescence-activated cell sorting.
    Miura I; Kobayashi Y; Takahashi N; Saitoh K; Miura AB
    Br J Haematol; 2000 Sep; 110(4):876-9. PubMed ID: 11054073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype.
    Cuneo A; Bigoni R; Cavazzini F; Bardi A; Roberti MG; Agostini P; Tammiso E; Ciccone N; Mancini M; Nanni M; De Cuia R; Divona M; La Starza R; Crescenzi B; Testoni N; Rege Cambrin G; Mecucci C; Lo Coco F; Saglio G; Castoldi G
    Leukemia; 2002 Sep; 16(9):1745-51. PubMed ID: 12200689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Confirmation of centromeric fusion in 7p/1q translocation associated with myelodysplastic syndrome.
    Hoo JJ; Szego K; Jones B
    Cancer Genet Cytogenet; 1992 Dec; 64(2):186-8. PubMed ID: 1486571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of monosomy 7 and trisomies 8 and 11 in myelodysplastic disorders by interphase fluorescent in situ hybridization. Comparison with acute non-lymphocytic leukemias.
    Brizard F; Brizard A; Guilhot F; Tanzer J; Berger R
    Leukemia; 1994 Jun; 8(6):1005-11. PubMed ID: 8207973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.